BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28596159)

  • 1. In Vivo Relationship Between Hypoxia and Angiogenesis in Human Glioblastoma: A Multimodal Imaging Study.
    Ponte KF; Berro DH; Collet S; Constans JM; Emery E; Valable S; Guillamo JS
    J Nucl Med; 2017 Oct; 58(10):1574-1579. PubMed ID: 28596159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI.
    Gerstner ER; Zhang Z; Fink JR; Muzi M; Hanna L; Greco E; Prah M; Schmainda KM; Mintz A; Kostakoglu L; Eikman EA; Ellingson BM; Ratai EM; Sorensen AG; Barboriak DP; Mankoff DA;
    Clin Cancer Res; 2016 Oct; 22(20):5079-5086. PubMed ID: 27185374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.
    Kawai N; Maeda Y; Kudomi N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):441-50. PubMed ID: 21072512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis.
    Bekaert L; Valable S; Lechapt-Zalcman E; Ponte K; Collet S; Constans JM; Levallet G; Bordji K; Petit E; Branger P; Emery E; Manrique A; Barré L; Bernaudin M; Guillamo JS
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1383-1392. PubMed ID: 28315948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.
    Hirata K; Terasaka S; Shiga T; Hattori N; Magota K; Kobayashi H; Yamaguchi S; Houkin K; Tanaka S; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):760-70. PubMed ID: 22307533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas.
    Szeto MD; Chakraborty G; Hadley J; Rockne R; Muzi M; Alvord EC; Krohn KA; Spence AM; Swanson KR
    Cancer Res; 2009 May; 69(10):4502-9. PubMed ID: 19366800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
    Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
    J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and
    Huang S; Michalek JE; Reardon DA; Wen PY; Floyd JR; Fox PT; Clarke GD; Jerabek PA; Schmainda KM; Muzi M; Hyun H; Lee EQ; Brenner AJ
    Sci Rep; 2021 Apr; 11(1):7632. PubMed ID: 33828310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas.
    Swanson KR; Chakraborty G; Wang CH; Rockne R; Harpold HL; Muzi M; Adamsen TC; Krohn KA; Spence AM
    J Nucl Med; 2009 Jan; 50(1):36-44. PubMed ID: 19091885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of hypoxia in human glioblastoma tumors with dynamic 18F-FMISO PET imaging.
    Abdo RA; Lamare F; Fernandez P; Bentourkia M
    Australas Phys Eng Sci Med; 2019 Dec; 42(4):981-993. PubMed ID: 31520369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing hypoxia in human glioma: A simultaneous multimodal MRI and PET study.
    Preibisch C; Shi K; Kluge A; Lukas M; Wiestler B; Göttler J; Gempt J; Ringel F; Al Jaberi M; Schlegel J; Meyer B; Zimmer C; Pyka T; Förster S
    NMR Biomed; 2017 Nov; 30(11):. PubMed ID: 28805936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor.
    Toyonaga T; Yamaguchi S; Hirata K; Kobayashi K; Manabe O; Watanabe S; Terasaka S; Kobayashi H; Hattori N; Shiga T; Kuge Y; Tanaka S; Ito YM; Tamaki N
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):611-619. PubMed ID: 27752745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images.
    Gu S; Chakraborty G; Champley K; Alessio AM; Claridge J; Rockne R; Muzi M; Krohn KA; Spence AM; Alvord EC; Anderson AR; Kinahan PE; Swanson KR
    Math Med Biol; 2012 Mar; 29(1):31-48. PubMed ID: 21562060
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Grkovski M; Emmas SA; Carlin SD
    J Nucl Med; 2017 Oct; 58(10):1567-1573. PubMed ID: 28360207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI,
    Collet S; Guillamo JS; Berro DH; Chakhoyan A; Constans JM; Lechapt-Zalcman E; Derlon JM; Hatt M; Visvikis D; Guillouet S; Perrio C; Bernaudin M; Valable S
    J Nucl Med; 2021 Oct; 62(10):1349-1356. PubMed ID: 34016725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric Imaging of Tumor Hypoxia and Perfusion with
    Grkovski M; Schöder H; Lee NY; Carlin SD; Beattie BJ; Riaz N; Leeman JE; O'Donoghue JA; Humm JL
    J Nucl Med; 2017 Jul; 58(7):1072-1080. PubMed ID: 28183993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival.
    Spence AM; Muzi M; Swanson KR; O'Sullivan F; Rockhill JK; Rajendran JG; Adamsen TC; Link JM; Swanson PE; Yagle KJ; Rostomily RC; Silbergeld DL; Krohn KA
    Clin Cancer Res; 2008 May; 14(9):2623-30. PubMed ID: 18451225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.
    Muzi M; Peterson LM; O'Sullivan JN; Fink JR; Rajendran JG; McLaughlin LJ; Muzi JP; Mankoff DA; Krohn KA
    J Nucl Med; 2015 Aug; 56(8):1223-8. PubMed ID: 26112020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FMISO-PET-derived brain oxygen tension maps: application to glioblastoma and less aggressive gliomas.
    Chakhoyan A; Guillamo JS; Collet S; Kauffmann F; Delcroix N; Lechapt-Zalcman E; Constans JM; Petit E; MacKenzie ET; Barré L; Bernaudin M; Touzani O; Valable S
    Sci Rep; 2017 Aug; 7(1):10210. PubMed ID: 28860608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET.
    Rockne RC; Trister AD; Jacobs J; Hawkins-Daarud AJ; Neal ML; Hendrickson K; Mrugala MM; Rockhill JK; Kinahan P; Krohn KA; Swanson KR
    J R Soc Interface; 2015 Feb; 12(103):. PubMed ID: 25540239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.